For: | Wei CH, Wei LX, Lai MY, Chen JZ, Mo XJ. Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells. World J Gastroenterol 2013; 19(8): 1239-1246 [PMID: 23482887 DOI: 10.3748/wjg.v19.i8.1239] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i8/1239.htm |
Number | Citing Articles |
1 |
Yan Wang. Identifying key stage-specific genes and transcription factors for gastric cancer based on RNA-sequencing data. Medicine 2017; 96(4): e5691 doi: 10.1097/MD.0000000000005691
|
2 |
Jun Hu, Xiaoting Wang. The relationship between rs968697 genetic polymorphism and gastric cancer susceptibility, TNM stage and survival prognosis. European Journal of Inflammation 2023; 21 doi: 10.1177/1721727X231216202
|
3 |
Shizhen Zhang, Qiuping Mo, Xiaochen Wang. Oncological role of HMGA2 (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4856
|
4 |
Uchenna Unachukwu, Kiran Chada, Jeanine D’Armiento. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia. International Journal of Molecular Sciences 2020; 21(9): 3151 doi: 10.3390/ijms21093151
|
5 |
Tsuyoshi Maruyama, Koji Saito, Masato Higurashi, Fumihiro Ishikawa, Yohko Kohno, Kazunori Mori, Motoko Shibanuma. HMGA2 drives the IGFBP1/AKT pathway to counteract the increase in P27KIP1 protein levels in mtDNA/RNA‐less cancer cells. Cancer Science 2023; 114(1): 152 doi: 10.1111/cas.15582
|
6 |
JUNHYUN LEE, SHINJUNG HA, CHAN-KWON JUNG, HAN HONG LEE. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. International Journal of Oncology 2015; 46(6): 2431 doi: 10.3892/ijo.2015.2947
|
7 |
Behzad Mansoori, Ali Mohammadi, Henrik J. Ditzel, Pascal H. G. Duijf, Vahid Khaze, Morten F. Gjerstorff, Behzad Baradaran. HMGA2 as a Critical Regulator in Cancer Development. Genes 2021; 12(2): 269 doi: 10.3390/genes12020269
|
8 |
Zhouying Wu, Min Wang, Feng Li, Feng Wang, Jianchao Jia, Zongqi Feng, Xue Huo, Jie Yang, Wen Jin, Rina Sa, Wenming Gao, Lan Yu. CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.707295
|
9 |
Maryam Moradi Binabaj, Atena Soleimani, Farzad Rahmani, Amir Avan, Majid Khazaei, Hamid Fiuji, Saman Soleimanpour, Mikhail Ryzhikov, Gordon A. Ferns, Afsane Bahrami, Seyed Mahdi Hassanian. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression. Gene 2019; 706: 131 doi: 10.1016/j.gene.2019.04.088
|
10 |
Wenhao Ren, Ling Gao, Fan Li, Cui Qiang, Shaoming Li, Jingjing Zheng, Xinjuan Kong, Jing Deng, Guangfeng Cai, Hao Zhang, Minzhan Zhou, Keqian Zhi. Circulating high mobility group AT‐hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2017; 46(10): 998 doi: 10.1111/jop.12609
|
11 |
Francesca Galdiero, Anna Maria Bello, Anna Spina, Anna Capiluongo, Sophie Liuu, Margot De Marco, Alessandra Rosati, Mario Capunzo, Maria Napolitano, Emilia Vuttariello, Mario Monaco, Daniela Califano, Maria Caterina Turco, Gennaro Chiappetta, Joëlle Vinh, Giovanni Chiappetta. Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysis. Oncotarget 2018; 9(8): 8016 doi: 10.18632/oncotarget.23858
|
12 |
|
13 |
Harpreet Kaur, Marianne Hütt-Cabezas, Melanie F. Weingart, Jingying Xu, Yasumichi Kuwahara, Anat Erdreich-Epstein, Bernard E. Weissman, Charles G. Eberhart, Eric H. Raabe. The Chromatin-Modifying Protein HMGA2 Promotes Atypical Teratoid/Rhabdoid Cell Tumorigenicity. Journal of Neuropathology & Experimental Neurology 2015; 74(2): 177 doi: 10.1097/NEN.0000000000000161
|